Acute Pediatric Asthma Exacerbation – Evidence‑Based Management

Initial Assessment & Severity Recognition

• Severe exacerbation is identified by inability to speak or feed, respiratory rate > 50 breaths/min, heart rate > 140 beats/min, use of accessory muscles, or peak expiratory flow (PEF) < 50 % of predicted (in children ≥ 5 years)【1】.
• Life‑threatening features include PEF < 33 % predicted, silent chest, cyanosis, poor respiratory effort, altered consciousness, or SpO₂ < 92 % despite supplemental oxygen【1】.
• In a breathless child, a normal or elevated PaCO₂ signals impending respiratory failure and should prompt urgent escalation【1】.

Immediate Treatment (First Hour)

• Bronchodilator – Give salbutamol 5 mg nebulized (or 2.5 mg for children ≤ 2 years or < 15 kg) via oxygen‑driven nebulizer every 20 minutes for three doses; alternative: terbutaline 10 mg (5 mg for young children)【1】【2】.
• Delivery option – A metered‑dose inhaler (MDI) with a large‑volume spacer (4–8 puffs) every 20 minutes for three doses is equally effective【2】.
• Oxygen – Provide high‑flow oxygen via face mask to keep SpO₂ > 92 %【1】.
• Systemic corticosteroid – Administer prednisolone 1–2 mg/kg orally (max 40–60 mg) immediately; continue 3–5 days without taper if course < 10 days【1】【2】. If vomiting or critically ill, give IV hydrocortisone 100 mg every 6 hours【1】【2】.
• Ipratropium bromide – Add 100–250 µg ipratropium to each nebulizer treatment for moderate‑to‑severe attacks; repeat every 6 hours until improvement begins【1】【2】.

Reassessment (15–30 minutes)

• Measure PEF (if age ≥ 5 years), respiratory rate, heart rate, and SpO₂【1】.

Response‑Guided Pathways

• Good response – PEF > 75 % predicted, minimal symptoms: continue usual maintenance therapy, monitor with a PEF chart, arrange follow‑up within 48 hours【1】.
• Incomplete response – PEF 50–75 % predicted, persistent symptoms: maintain high‑flow oxygen, continue prednisolone, give nebulized β‑agonist every 4 hours, consider hospital admission【1】.
• Poor response – PEF < 50 % predicted or ongoing severe features: increase nebulized β‑agonist to every 15–30 minutes, continue ipratropium q6 h, arrange immediate admission【1】.

Escalation for Refractory Cases

• If no improvement after the first reassessment, increase salbutamol frequency to every 15–30 minutes or switch to continuous nebulization, ensure ipratropium is added, and continue oxygen and systemic steroids【1】.
• For life‑threatening deterioration, give IV aminophylline 5 mg/kg over 20 minutes followed by a maintenance infusion of 1 mg/kg/hour; do not give a loading dose if the child is already on oral theophylline【1】【2】.
• Prepare for ICU transfer when indicated【1】.

Ongoing Monitoring

• Record PEF before and after each β‑agonist dose at least four times daily【1】.
• Continuously monitor SpO₂, aiming for > 92 %; watch for tachycardia (expected) and bradycardia (ominous)【1】.

Hospital Admission Criteria

• Immediate admission is required for any life‑threatening feature, persistent severe attack after initial therapy, PEF < 50 % after 1–2 hours of intensive treatment, inability of caregivers to manage at home, or early deterioration after bronchodilators【1】.
• A lower threshold for admission applies for evening presentations, recent nocturnal symptoms, prior severe attacks, or poor social support【1】.

ICU Transfer Criteria

• Transfer to intensive care is indicated for worsening PEF despite treatment, increasing exhaustion or feeble respirations, persistent/worsening hypoxia (SpO₂ < 92 %) or hypercapnia, altered consciousness, or respiratory arrest/coma【1】.

Critical Pitfalls to Avoid

• Sedatives are absolutely contraindicated in acute pediatric asthma【1】.
• Do not give an aminophylline bolus to children already receiving oral theophylline【1】.
• Do not rely solely on subjective assessment; obtain objective measurements (PEF, SpO₂)【1】.

Discharge Planning (When Stable)

• Discharge is appropriate when the child has been on stable medication for ≥ 24 hours with verified inhaler technique, PEF > 75 % predicted, diurnal PEF variability < 25 %, and minimal or absent symptoms【1】.
• Prescribe prednisolone 1–2 mg/kg daily to complete a total 3–5‑day course, continue inhaled corticosteroids alongside bronchodilators, and provide a personal PEF meter with a written self‑management plan【1】.
• Arrange GP follow‑up within 1 week and respiratory clinic review within 4 weeks【1】.

Levosalbutamol (R‑enantiomer) Considerations

• International pediatric asthma guidelines (e.g., British Thoracic Society) recommend racemic salbutamol as the standard bronchodilator for acute attacks【1】【2】.
• Small studies suggest levosalbutamol may yield modestly better SpO₂, PEFR, and asthma scores, with less tachycardia and hypokalemia, but the evidence is limited and not incorporated into major guidelines【1】【2】.
• If levosalbutamol is chosen, apply the same dosing schedule (approximately half the milligram dose of racemic salbutamol) and escalation protocol described for standard salbutamol【1】【2】.

Management of Moderate to Severe Acute Asthma Exacerbation in Children

Immediate Treatment Protocol

• The American Academy of Pediatrics recommends administering high-flow oxygen via face mask immediately to maintain oxygen saturation >92% in all children with moderate to severe exacerbation 3, 4
• The American Thoracic Society suggests that continuous pulse oximetry should be maintained throughout treatment 3
• The British Thoracic Society recommends giving salbutamol 5 mg via oxygen-driven nebulizer or 4-8 puffs via metered-dose inhaler with large volume spacer every 20 minutes for up to 3 doses in the first hour 3, 4
• For children ≤2 years, the American Academy of Pediatrics recommends reducing the nebulized dose to 2.5 mg 4
• The Global Initiative for Asthma suggests that MDI with spacer is equally effective to nebulization and may result in lower admission rates, particularly in severe exacerbations, with fewer cardiovascular side effects 3
• The American College of Chest Physicians recommends adding ipratropium 100 mcg to the nebulizer immediately for moderate to severe exacerbations 3, 4
• The European Respiratory Society suggests repeating ipratropium every 6 hours until improvement starts 5, 3

Assessment of Severity

• The American Thoracic Society identifies features indicating severe exacerbation, including being too breathless to talk or feed, respiratory rate >50 breaths/minute, pulse >140 beats/minute, peak expiratory flow <50% predicted, and use of accessory muscles 5, 3
• The British Thoracic Society suggests that life-threatening features requiring escalation include peak flow <33% predicted or poor respiratory effort, silent chest, cyanosis, or exhaustion, altered level of consciousness or agitation, and oxygen saturation <92% despite supplemental oxygen 5, 3

Monitoring and Reassessment

• The American Academy of Pediatrics recommends repeating peak expiratory flow measurement 15-30 minutes after starting treatment 5, 3
• The Global Initiative for Asthma suggests reassessing clinical status after each set of bronchodilator doses 3, 4
• The European Respiratory Society recommends charting PEF before and after β-agonist administration at least 4 times daily throughout hospital stay 5, 3

Subsequent Management Based on Response

• The American College of Chest Physicians recommends continuing high-flow oxygen, prednisolone 1-2 mg/kg daily, and nebulized β-agonist 4 hourly if the patient is improving after initial treatment 5, 3
• The American Thoracic Society suggests increasing nebulized β-agonist frequency up to every 30 minutes if the patient is not improving after 15-30 minutes 5, 3

Critical Pitfalls to Avoid

• The American Academy of Pediatrics recommends not delaying systemic corticosteroids while giving repeated albuterol doses alone, as this is a common cause of treatment failure and preventable mortality 3
• The Global Initiative for Asthma suggests not using sedatives of any kind in acute severe asthma, as they can depress respiratory function 3

Hospital Admission Criteria

• The American College of Chest Physicians recommends hospital admission for persistent features of severe asthma after initial treatment, peak expiratory flow remaining <50% predicted, life-threatening features, or parents unable to give appropriate treatment at home 3, 5

Transfer to Intensive Care Unit

• The European Respiratory Society recommends transfer to intensive care unit if there is deteriorating peak flow, worsening exhaustion, persistent hypoxemia or hypercapnia, altered consciousness, confusion, or drowsiness, or respiratory arrest 5, 3

Levosalbutamol Nebulization Dosing in Pediatric Acute Asthma

Initial Intensive Dosing (First Hour)

• In children with an acute asthma exacerbation, give levosalbutamol by nebulizer at 0.075 mg/kg per dose (minimum 1.25 mg) every 20 minutes for three consecutive doses during the first hour. This weight‑based regimen provides rapid bronchodilation in the intensive phase. 6

Subsequent Maintenance Dosing (After the First Hour)

• After the intensive phase, continue levosalbutamol at 0.075–0.15 mg/kg every 1–4 hours as needed, with a practical maximum single dose of 1.25 mg for most children. This allows flexible titration based on clinical response while staying within safe limits. 6
• The corresponding adult‑equivalent dose is 1.25–2.5 mg administered every 1–4 hours for comparable bronchodilator effect. 6

Dose Equivalence to Racemic Albuterol

• Levosalbutamol is administered at approximately half the milligram dose of racemic albuterol to achieve comparable efficacy and safety in pediatric patients. 6

Safety Monitoring During High‑Frequency or High‑Dose Therapy

• When levosalbutamol is given at the higher end of the dosing range or at frequent intervals, monitor for tachycardia, tremor, and hypokalemia as expected adverse effects. Close observation is recommended to detect and manage these events promptly. 6

Clinical Algorithm for Moderate and Severe Exacerbations

• Moderate exacerbation (PEF 50–75 % predicted): start with the intensive dosing described above (0.075 mg/kg, min 1.25 mg, every 20 min × 3 doses). Reassess after 15–30 minutes; if improvement is seen, continue 0.075–0.15 mg/kg every 4 hours. 6
• Severe exacerbation (PEF < 50 % predicted): use the same intensive dosing (0.075 mg/kg, min 1.25 mg, every 20 min × 3 doses). If no improvement after the first hour, consider increasing frequency to every 15–30 minutes or switching to continuous nebulization, while maintaining the same per‑dose amount. 6